{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-25T12:23:10.018110+00:00",
  "news": [
    {
      "title": "Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug - Reuters",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQRVY0cUNrMzFCRHl2MU5lMFliV1NhZThyWkhCdlpha0x4aXk0YTRoaUgzTGtudnphWDdJaW5VUzVDZ2Npb1RNaFl6SjZuclBUNk43WE9ZMGFWV29VQllDRmQtT0pnazY4MGN3MVNtRTk4a0tOeWEzdW5sOVl6ZUxzT3VobXhLQnFlSHJnWTRVZ1p5M0I0ejhNRXZ4aVVtRTh0OUtETXdHSzAzVFcwYUlRRTl2MkxWeEpGN201NQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQRVY0cUNrMzFCRHl2MU5lMFliV1NhZThyWkhCdlpha0x4aXk0YTRoaUgzTGtudnphWDdJaW5VUzVDZ2Npb1RNaFl6SjZuclBUNk43WE9ZMGFWV29VQllDRmQtT0pnazY4MGN3MVNtRTk4a0tOeWEzdW5sOVl6ZUxzT3VobXhLQnFlSHJnWTRVZ1p5M0I0ejhNRXZ4aVVtRTh0OUtETXdHSzAzVFcwYUlRRTl2MkxWeEpGN201NQ?oc=5\" target=\"_blank\">Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-25T11:17:15+00:00",
      "source": "Reuters"
    },
    {
      "title": "Reversal indicators forming on Amgen Inc. stock - Dollar Strength & Safe Capital Growth Trade Ideas - Newser",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOOXlxUUNBQm1aMGtRT2RpUDR2Z2JPb29URUcyNFV5QjcyazlDZlFVMVk1R3VvckJ3Q3JOaVJSc05Ha0p5UE81TUdNalAzV3l6RXRTLXprTWtBNGI4UVgwc0M4dmFkRjd4UWZQUEctcGI3ek9kR2RkWUR0WkNqYk1UOGJZb2FNWmJo?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOOXlxUUNBQm1aMGtRT2RpUDR2Z2JPb29URUcyNFV5QjcyazlDZlFVMVk1R3VvckJ3Q3JOaVJSc05Ha0p5UE81TUdNalAzV3l6RXRTLXprTWtBNGI4UVgwc0M4dmFkRjd4UWZQUEctcGI3ek9kR2RkWUR0WkNqYk1UOGJZb2FNWmJo?oc=5\" target=\"_blank\">Reversal indicators forming on Amgen Inc. stock - Dollar Strength & Safe Capital Growth Trade Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-25T05:25:59+00:00",
      "source": "Newser"
    },
    {
      "title": "Royalty Pharma To Acquire Royalty Interest in Amgen’s Imdelltra For $950 Million - citybiz",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVHhvM2ZXVDNRZ0RvcGt1MEdGS0Q3OHhwM1BUa1ZnYWFGMVc4YzVZTkxRT0FteGkxeDZCaEhXc2dxYTFFdk9UbTh6WnlvdzV6eUtJSFM0SWdKSnktbmFveUo4czd6b3NEUE5kMTgwY3FaYzBOQ1dhekd1T0VmeUlobGlzOW54UFhLX0NvaXZKTldlU0lmbFUxNC1xSk1Ub05hU3E3Y2pJdUFSbzRHbktod24waDF5ZDY4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVHhvM2ZXVDNRZ0RvcGt1MEdGS0Q3OHhwM1BUa1ZnYWFGMVc4YzVZTkxRT0FteGkxeDZCaEhXc2dxYTFFdk9UbTh6WnlvdzV6eUtJSFM0SWdKSnktbmFveUo4czd6b3NEUE5kMTgwY3FaYzBOQ1dhekd1T0VmeUlobGlzOW54UFhLX0NvaXZKTldlU0lmbFUxNC1xSk1Ub05hU3E3Y2pJdUFSbzRHbktod24waDF5ZDY4?oc=5\" target=\"_blank\">Royalty Pharma To Acquire Royalty Interest in Amgen’s Imdelltra For $950 Million</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">citybiz</font>",
      "published": "2025-08-25T11:04:21+00:00",
      "source": "citybiz"
    },
    {
      "title": "Candriam S.C.A. Sells 111,322 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQc0VCTm5YbGJTeFZKN2d3OWpSVHRGYlhGbHJJeGtuY0p5ZXBYc2IzWjMzUVQ1ZWJ6WGhDaEdXRE9zeDJYRW9FWnczOVUtYksyNFd3NUVrMFpIMlE4MUxYWm51TEE0V21rS1kyTkpyNGI4MEFZUWViT3BVQVA0Y3g0ZXFpdkRiN0d5VlJRenVjTGFVQ2xHQlZSLUhyWTRIOWhRWnNMb29JWlJYbVlkaDdaTTBsa3hDcnp6V1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxQc0VCTm5YbGJTeFZKN2d3OWpSVHRGYlhGbHJJeGtuY0p5ZXBYc2IzWjMzUVQ1ZWJ6WGhDaEdXRE9zeDJYRW9FWnczOVUtYksyNFd3NUVrMFpIMlE4MUxYWm51TEE0V21rS1kyTkpyNGI4MEFZUWViT3BVQVA0Y3g0ZXFpdkRiN0d5VlJRenVjTGFVQ2xHQlZSLUhyWTRIOWhRWnNMb29JWlJYbVlkaDdaTTBsa3hDcnp6V1E?oc=5\" target=\"_blank\">Candriam S.C.A. Sells 111,322 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-25T10:30:16+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Stock Analysis | Amgen Outlook - Mixed Signals Amid Strong Fundamentals and Volatile Technicals - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbGpQZzFXZ2psQkZCNTZjN3VLUjRUSW5oLS13dTB3cjR5RGk0WkpCZWVHNld6WkFQTXVMZEl0V2t4bTBBTl9XLXprcjhUWlZfZlBvcUdoRDFkTThjZlNKMXd0UGg2VHAtTEpoc3M4aEI3MXYza3JGUVZvbC1fNWYtQzhubFdTRkxSWVZDOTlCUGZpa2xUQVVCeG93bExob19qSklvT1B2Zm9KS0RJQmlaOXAzRWEwUW8x?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbGpQZzFXZ2psQkZCNTZjN3VLUjRUSW5oLS13dTB3cjR5RGk0WkpCZWVHNld6WkFQTXVMZEl0V2t4bTBBTl9XLXprcjhUWlZfZlBvcUdoRDFkTThjZlNKMXd0UGg2VHAtTEpoc3M4aEI3MXYza3JGUVZvbC1fNWYtQzhubFdTRkxSWVZDOTlCUGZpa2xUQVVCeG93bExob19qSklvT1B2Zm9KS0RJQmlaOXAzRWEwUW8x?oc=5\" target=\"_blank\">Stock Analysis | Amgen Outlook - Mixed Signals Amid Strong Fundamentals and Volatile Technicals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-25T06:50:09+00:00",
      "source": "AInvest"
    },
    {
      "title": "Royalty Pharma to buy royalty interest in Amgen’s Imdelltra for up to $950M - MSN",
      "link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNSVExN0JOMmpqWm1VM0tZUDBGX2FERVB4X1RYMElEQ09wQTUyV25mdzlUelM1eHRqa3Q5OUlrSHFQWFpJVTJ0OHNfaWl5ZExxSl9oR3RfQXhSdkVrOEJxZmlvOENOZFhJaXFJaGNBbHNqNUZhd3VQVjl2V2Zsd2FmSW1QRzNiOXJKb3lTTVFKaDZJaF9yYXRyMll2Y1E0bGtPNjZPNDdJM0dJQnp4a2ZtbTNtMzBadE9ndXBCQUdPaXJFZVZlcDRBRWV5Y1NaZHFqcmFaQ1lwLU16SEZzVWJLZ3NxNHZZRnM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNSVExN0JOMmpqWm1VM0tZUDBGX2FERVB4X1RYMElEQ09wQTUyV25mdzlUelM1eHRqa3Q5OUlrSHFQWFpJVTJ0OHNfaWl5ZExxSl9oR3RfQXhSdkVrOEJxZmlvOENOZFhJaXFJaGNBbHNqNUZhd3VQVjl2V2Zsd2FmSW1QRzNiOXJKb3lTTVFKaDZJaF9yYXRyMll2Y1E0bGtPNjZPNDdJM0dJQnp4a2ZtbTNtMzBadE9ndXBCQUdPaXJFZVZlcDRBRWV5Y1NaZHFqcmFaQ1lwLU16SEZzVWJLZ3NxNHZZRnM?oc=5\" target=\"_blank\">Royalty Pharma to buy royalty interest in Amgen’s Imdelltra for up to $950M</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-08-25T10:34:44+00:00",
      "source": "MSN"
    },
    {
      "title": "Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million - Reuters",
      "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPUlR3ZEtrZ1VRMHpWSTEybnNkQUxJZS16Qzc5enJRTHlQN3Q2MVotZzNnUHpjWXBtS0dXOFdYLTBuLWlSTG9tVDJZLUFGVVQ3MFU0bGxOQzhRakNPXzZKUXZ4cUYyclpGa25MZXpVTURZYm8xb0gyV1Rfbld1bTJlNWFZUWdLTnZHMUhVWVpQanJQYmZtYjdfX3huVVBkcGFQdnAtVmliMFo1VUtTcXlWZjNNMnNfQjNRck9TUlFORUIxZjBMR2c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixgFBVV95cUxPUlR3ZEtrZ1VRMHpWSTEybnNkQUxJZS16Qzc5enJRTHlQN3Q2MVotZzNnUHpjWXBtS0dXOFdYLTBuLWlSTG9tVDJZLUFGVVQ3MFU0bGxOQzhRakNPXzZKUXZ4cUYyclpGa25MZXpVTURZYm8xb0gyV1Rfbld1bTJlNWFZUWdLTnZHMUhVWVpQanJQYmZtYjdfX3huVVBkcGFQdnAtVmliMFo1VUtTcXlWZjNNMnNfQjNRck9TUlFORUIxZjBMR2c?oc=5\" target=\"_blank\">Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-25T10:38:35+00:00",
      "source": "Reuters"
    },
    {
      "title": "Dorsey & Whitney Trust CO LLC Boosts Holdings in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNRERNODdKaDdOdkh3ZzBYMzRQOWVDV1J1Y09JYnVlbjlDVDdQeHBrbHZJamhoYkszQ2JQcElLREVHMGh3N2puaXZlMUpVdThDeklpNGpaWVZ6Wk1aVTd1RjBZRERaNXRuUGRBSUE4S0NjZ3M1OTNiWU1zOTBYVXRrVlJjckFnZy1KT1VYS2d6WWpFUkFlXzhXSGJMaEFSVUFkTW1jcjZnZ3dpdEFWV2x5bXhVQURYLTR2TGtXcTcwWQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNRERNODdKaDdOdkh3ZzBYMzRQOWVDV1J1Y09JYnVlbjlDVDdQeHBrbHZJamhoYkszQ2JQcElLREVHMGh3N2puaXZlMUpVdThDeklpNGpaWVZ6Wk1aVTd1RjBZRERaNXRuUGRBSUE4S0NjZ3M1OTNiWU1zOTBYVXRrVlJjckFnZy1KT1VYS2d6WWpFUkFlXzhXSGJMaEFSVUFkTW1jcjZnZ3dpdEFWV2x5bXhVQURYLTR2TGtXcTcwWQ?oc=5\" target=\"_blank\">Dorsey & Whitney Trust CO LLC Boosts Holdings in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-25T10:30:14+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "UK court clears the way for Amgen and Samsung to launch biosimilars - Life Sciences Intellectual Property Review",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5\" target=\"_blank\">UK court clears the way for Amgen and Samsung to launch biosimilars</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Life Sciences Intellectual Property Review</font>",
      "published": "2025-05-22T07:00:00+00:00",
      "source": "Life Sciences Intellectual Property Review"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-22",
      "close": 293.7200012207031
    },
    "history": [
      {
        "date": "2025-08-14",
        "close": 287.95404052734375
      },
      {
        "date": "2025-08-15",
        "close": 294.08428955078125
      },
      {
        "date": "2025-08-18",
        "close": 290.2652587890625
      },
      {
        "date": "2025-08-19",
        "close": 293.17169189453125
      },
      {
        "date": "2025-08-20",
        "close": 294.064453125
      },
      {
        "date": "2025-08-21",
        "close": 293.3800048828125
      },
      {
        "date": "2025-08-22",
        "close": 293.7200012207031
      }
    ],
    "name": "Amgen Inc."
  }
}